OP

Olanchery Puthan House Mohandas

Active Director Director DIN 01132760
DIN 01132760 First appointment Mar 2007 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Olanchery Puthan House Mohandas

Data last updated:

Olanchery Puthan House Mohandas is a Director at Bluemed Drugs Private Limited (since 2007). The company operates in Trading.

DIN 01132760
Primary Designation Director
Industry Trading
First Appointment 07 Mar 2007
Oldest Company Age 19 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bluemed Drugs Private Limited U24239KL2007PTC020452
Director07 Mar 20072007Active

Board colleagues of Olanchery Puthan House Mohandas

Directorship timeline

Open interactive timeline →
Bluemed Drugs Private Limited
Premium access

Shareholding and investment profile for Olanchery Puthan House Mohandas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Olanchery Puthan House Mohandas

Olanchery Puthan House Mohandas currently holds 1 directorship: Bluemed Drugs Private Limited (Director, since 07 Mar 2007).

Olanchery Puthan House Mohandas was first appointed on 07 Mar 2007 as Director at Bluemed Drugs Private Limited.

The current boards of Olanchery Puthan House Mohandas's companies include Olanchery Muralidharan (Bluemed Drugs Private Limited), Premakumar Sekharipuram Chinnappa (Bluemed Drugs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available